Shares of Cyclerion Therapeutics climbed after the company entered an agreement to integrate Medsteer's technology into its lead program in development for treatment-resistant depression. The stock ...

Cyclerion Therapeutics entered an agreement to integrate Medsteer's technology into CYC-126, its lead program in development for treatment-resistant depression.

Cyclerion Strengthens Development of Closed-Loop Anesthetic Platform through Strategic Collaboration Agreement with Medsteer –– Comprehensive ...

Investing.com -- Cyclerion Therapeutics Inc (NASDAQ:CYCN) stock soared 44.2% in after-hours trading Monday following the announcement of a strategic collaboration with Medsteer to advance its ...

Please provide your email address to receive an email when new articles are posted on . You've successfully added to your alerts. You will receive an email when new content is published. Click Here to ...

A groundbreaking study led by Tulsa’s Laureate Institute for Brain Research has identified genetic and cognitive risk factors linked to treatment-resistant depression, offering new hope for more ...

While research is new and not legal in every state, psychedelic treatments show promising results for treatment-resistant depression, PTSD, and other mental health conditions. Share on Pinterest ...

Please provide your email address to receive an email when new articles are posted on . Researchers analyzed data from patients with treatment-resistant depression given ketamine or electroconvulsive ...

AUSTIN (KXAN)- Experts estimate that treatment-resistant depression (TRD) impacts about 2.8 million Americans annually, and a groundbreaking implantable device may offer new hope. Depression affects ...

Editor’s note: If you or someone you know is struggling with suicidal thoughts or mental health matters, please call the 988 Suicide & Crisis Lifeline by dialing 988 to connect with a trained ...